Compare RPRX & HPQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RPRX | HPQ |
|---|---|---|
| Founded | 1996 | 1939 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.7B | 17.8B |
| IPO Year | 2020 | 2002 |
| Metric | RPRX | HPQ |
|---|---|---|
| Price | $46.15 | $18.68 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 12 |
| Target Price | ★ $47.75 | $21.42 |
| AVG Volume (30 Days) | 2.7M | ★ 17.0M |
| Earning Date | 05-06-2026 | 05-25-2026 |
| Dividend Yield | 2.06% | ★ 6.34% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.78 | 0.58 |
| Revenue | $2,378,193,000.00 | ★ $55,295,000,000.00 |
| Revenue This Year | $38.30 | $3.16 |
| Revenue Next Year | $4.80 | $0.40 |
| P/E Ratio | ★ $25.63 | $32.59 |
| Revenue Growth | ★ 5.06 | 3.24 |
| 52 Week Low | $29.66 | $17.56 |
| 52 Week High | $47.86 | $29.55 |
| Indicator | RPRX | HPQ |
|---|---|---|
| Relative Strength Index (RSI) | 58.07 | 44.76 |
| Support Level | $44.94 | $18.32 |
| Resistance Level | $46.14 | $19.58 |
| Average True Range (ATR) | 0.92 | 0.63 |
| MACD | -0.23 | 0.08 |
| Stochastic Oscillator | 39.36 | 60.30 |
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
HP (formerly Hewlett-Packard) is a behemoth in the PC and printing markets. It has focused on these markets since it exited IT infrastructure in 2015 with the split from Hewlett Packard Enterprise. HP focuses on the commercial market, but maintains sales of consumer devices and printers. The firm has a broad and global customer base, with only one third of sales coming from the US. HP completely outsources manufacturing and relies heavily on channel partners for its sales and marketing.